MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Exact Sciences Corporation - Common Stock (NQ:EXAS)

104.91 UNCHANGED
Last Price Updated: 4:00 PM EDT, Mar 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 104.91
Bid (Size) 104.94 (100)
Ask (Size) 104.99 (500)
Prev. Close 104.91
Today's Range 104.91 - 104.91
52wk Range 38.81 - 104.91
Shares Outstanding 171,948,769
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
The Great Rebound: US Megadeals Surge 319% as Corporate Consolidation Returns with a Vengeance
The first quarter of 2026 has signaled a definitive end to the "deal drought" that plagued the previous three years, as American corporations embark on an unprecedented wave of consolidation. Driven by... 
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
The Great Divergence: Q1 2026 M&A Hits Record $813.3 Billion Amidst "K-Shaped" Recovery
As the first quarter of 2026 draws to a close, the global mergers and acquisitions (M&A) market has delivered a paradox that is reshaping the financial landscape. Preliminary data reveals that total... 
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property

Performance

YTD
+3.1%
+3.1%
1 Month
+1.2%
+1.2%
3 Month
+3.2%
+3.2%
6 Month
+76.9%
+76.9%
1 Year
+160.3%
+160.3%

More News

Read More
EXACT SCIENCES CORP (NASDAQ:EXAS) Shows Strong Technical and Fundamental Momentum ↗
Via Chartmill
News headline image
Abbott Laboratories Finalizes $21 Billion Acquisition of Exact Sciences, Redefining the Future of Cancer Diagnostics
Via MarketMinute
Topics Supply Chain
News headline image
Clearwater Analytics Stock Lands $37 Million Investment Amid 77% ARR Growth Surge and Pending Buyout ↗
Via The Motley Fool
News headline image
This $19.8 Million Bet on Commvault Comes Amid a 51% Drop. Here’s What Investors Should Know ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
The Record-Breaking M&A Renaissance of 2026: Why Deal Values are Soaring as Volume Dips
Via MarketMinute
Topics Artificial Intelligence Economy Workforce
News headline image
1 Magnificent Dividend Stock Down 22% That's a Screaming Buy Right Now ↗
Via The Motley Fool
News headline image
Exact Sciences to Present New Molecular Residual Disease and Multi-Cancer Early Detection Data at AACR 2026
From Exact Sciences Corp.
Via Business Wire
News headline image
1 Mid-Cap Stock to Consider Right Now and 2 Facing Headwinds
Via StockStory
News headline image
Hedge Fund Beryl Capital Initiated a Position in CSG Systems Worth Over $54 Million. Is the Stock a Buy? ↗
Via The Motley Fool
News headline image
Macroeconomic Headwinds and Shifting Demand Force Healthcare Giants to Trim 2026 Outlooks
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
3 Cash-Producing Stocks We Approach with Caution
Via StockStory
News headline image
The Return of the Titans: M&A Volume Set to Surge 20% in 2026 Amidst "Animal Spirits"
Via MarketMinute
Topics Artificial Intelligence Economy World Trade
News headline image
Exact Sciences Named Gallup Exceptional Workplace Award Winner for Third Consecutive Year
From Exact Sciences Corp.
Via Business Wire
News headline image
Marking National Colorectal Cancer Awareness Month, Privia Health Program Achieves 84% Colorectal Cancer Screening Rate Through Industry Collaboration
From Amalgam Rx, Inc.
Via Business Wire
News headline image
Forget Tilray: This Steady Income Stock Beats Wild Cannabis Swings Every Time ↗
Via The Motley Fool
Topics Cannabis Initial Public Offering
News headline image
Medtronic Hits 10-Quarter High: PFA Dominance and Robotic Surges Signal a New Era for MedTech
Via MarketMinute
Topics Artificial Intelligence Earnings Economy
News headline image
Exact Sciences Stockholders Approve Acquisition by Abbott
From Exact Sciences Corp.
Via Business Wire
News headline image
Boston Scientific’s $14.5B Penumbra Mega-Merger: A Strategic Reshaping of the Medtech Landscape
Via MarketMinute
News headline image
3 Unpopular Stocks We Approach with Caution
Via StockStory
Topics Economy
News headline image
3 Overrated Stocks That Concern Us
Via StockStory
News headline image
Exact Sciences Announces Record Fourth Quarter and Full Year 2025 Results
From Exact Sciences Corp.
Via Business Wire
News headline image
Abbott Labs: The Healthcare Dividend Stock I'd Happily Hold Forever ↗
Via The Motley Fool
News headline image
Halper Sadeh LLC is Investigating Whether CTRA, EXAS, NFBK are Obtaining Fair Deals for their Shareholders
From Halper Sadeh LLC
Via GlobeNewswire

Frequently Asked Questions

Is Exact Sciences Corporation - Common Stock publicly traded?
Yes, Exact Sciences Corporation - Common Stock is publicly traded.
What exchange does Exact Sciences Corporation - Common Stock trade on?
Exact Sciences Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Exact Sciences Corporation - Common Stock?
The ticker symbol for Exact Sciences Corporation - Common Stock is EXAS on the Nasdaq Stock Market
What is the current price of Exact Sciences Corporation - Common Stock?
The current price of Exact Sciences Corporation - Common Stock is 104.91
When was Exact Sciences Corporation - Common Stock last traded?
The last trade of Exact Sciences Corporation - Common Stock was at 03/20/26 04:00 PM ET
What is the market capitalization of Exact Sciences Corporation - Common Stock?
The market capitalization of Exact Sciences Corporation - Common Stock is 18.04B
How many shares of Exact Sciences Corporation - Common Stock are outstanding?
Exact Sciences Corporation - Common Stock has 18B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story